The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis
Open accessAbstract
BACKGROUND: Infectious mononucleosis-related Epstein-Barr virus (EBV) infection has been associated with an increased risk of Hodgkin's lymphoma in young adults. Whether the association is causal remains unclear. METHODS: We compared the incidence rates of Hodgkin's lymphoma in two population-based Danish cohorts of patients who were tested for infectious mononucleosis: 17,045 with serologic evidence of having had acute EBV infection, and 24,614 with no such evidence. We combined the cohort of patients who had serologically verified infectious mononucleosis with a cohort of 21,510 Swedish patients with infectious mononucleosis (combined total, 38,555). Biopsy specimens of Hodgkin's lymphomas occurring during follow-up in this combined cohort were tested serologically for the presence of EBV. Using this information, we modeled the relative risk of EBV-negative and EBV-positive Hodgkin's lymphoma in different periods after the diagnosis of infectious mononucleosis and estimated the median incubation time for mononucleosis-related EBV-positive Hodgkin's lymphoma. RESULTS: Only serologically confirmed infectious mononucleosis was associated with a persistently increased risk of Hodgkin's lymphoma. Sixteen of 29 tumors (55 percent), obtained from patients with infectious mononucleosis, had evidence of EBV. There was no evidence of an increased risk of EBV-negative Hodgkin's lymphoma after infectious mononucleosis. In contrast, the risk of EBV-positive Hodgkin's lymphoma was significantly increased (relative risk, 4.0; 95 percent confidence interval, 3.4 to 4.5). The estimated median incubation time from mononucleosis to EBV-positive Hodgkin's lymphoma was 4.1 years (95 percent confidence interval, 1.8 to 8.3). CONCLUSIONS: A causal association between infectious mononucleosis-related EBV infection and the EBV-positive subgroup of Hodgkin's lymphomas is likely in young adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Cancer Epidemiology and Prevention
(2006) · doi:10.1093/acprof:oso/9780195149616.001.0001 · Cited by 3,369
Huerta, G. T., & Villasana, J. E. M. (1988) · PubMed · Cited by 804
Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data
Glaser, S. L., Lin, R. J., Stewart, S. L., Ambinder, R. F., Jarrett, R. F., Brousset, P., Pallesen, G., Gulley, M. L., Khan, G., O'Grady, J., et al. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970207)70:4<375::aid-ijc1>3.0.co;2-t · Cited by 506
Childhood Social Environment and Hodgkin's Disease
Gutensohn, N., & Cole, P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101153040302 · Cited by 319
Epidemiology of Hodgkin's disease in the young
Gutensohn, N., & Cole, P. (1977) · International Journal of Cancer · doi:10.1002/ijc.2910190502 · Cited by 176
Gammaherpesviruses and “Hit-and-Run” Oncogenesis
Ambinder, R. F. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64697-4 · Cited by 147
HAAHR, S., Koch-Henriksen, N., Møller-Larsen, A., Eriksen, L. S., & Andersen, H. M. K. (1995) · Multiple Sclerosis Journal · doi:10.1177/135245859500100203 · Cited by 105
Cited by
Persistence of the Epstein–Barr Virus and the Origins of Associated Lymphomas
Thorley-Lawson, D. A., & Gross, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032015 · Cited by 1,054
Epstein-Barr virus: Biology and clinical disease
Damania, B., Kenney, S. C., & Raab-Traub, N. (2022) · Cell · doi:10.1016/j.cell.2022.08.026 · Cited by 612
Luzuriaga, K., & Sullivan, J. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1001116 · Cited by 606
Farrell, P. J. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-013023 · Cited by 541
Primary Epstein-Barr virus infection
Dunmire, S. K., Verghese, P. S., & Balfour, H. H. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.03.001 · Cited by 520
Hodgkin lymphoma: A review and update on recent progress
Shanbhag, S., & Ambinder, R. F. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21438 · Cited by 481
Chronic Inflammation: A Common and Important Factor in the Pathogenesis of Neoplasia
Schottenfeld, D., & Beebe-Dimmer, J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.69 · Cited by 475
Latency and lytic replication in Epstein–Barr virus-associated oncogenesis
Münz, C. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0249-7 · Cited by 469
Sokal, E. M., Hoppenbrouwers, K., Vandermeulen, C., Moutschen, M., Léonard, P., Moreels, A., Haumont, M., Bollen, A., Smets, F., & Denis, M. (2007) · The Journal of Infectious Diseases · doi:10.1086/523813 · Cited by 426
Epidemiology and Etiology of Leukemia and Lymphoma
Bispo, J. A. B., Pinheiro, P. S., & Kobetz, E. K. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034819 · Cited by 319
Dojcinov, S. D., Venkataraman, G., Pittaluga, S., Wlodarska, I., Schrager, J. A., Raffeld, M., Hills, R. K., & Jaffe, E. S. (2011) · Blood · doi:10.1182/blood-2010-12-323238 · Cited by 314
Enigmatic sex disparities in cancer incidence
Edgren, G., Liang, L., Adami, H.-O., & Chang, E. T. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-011-9647-5 · Cited by 277
Balfour, H. H., Sifakis, F., Sliman, J. A., Knight, J. A., Schmeling, D. O., & Thomas, W. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit321 · Cited by 266
Epstein–Barr Virus Infection and Multiple Sclerosis: A Review
Ascherio, A., & Munger, K. L. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9201-3 · Cited by 259
Gandhi, M. K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J., & Khanna, R. (2006) · Blood · doi:10.1182/blood-2006-04-015164 · Cited by 255
Chijioke, O., Müller, A., Feederle, R., Barros, M. H. M., Krieg, C., Emmel, V., Marcenaro, E., Leung, C. S., Antsiferova, O., Landtwing, V., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.041 · Cited by 258
Cancer Vaccines, Adjuvants, and Delivery Systems
Paston, S. J., Brentville, V. A., Symonds, P., & Durrant, L. G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.627932 · Cited by 200
Long-term cancer risk among people diagnosed with AIDS during childhood
Simard, E. P., Shiels, M. S., Bhatia, K., & Engels, E. A. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0823 · Cited by 50
Epstein-Barr Virus and Multiple Sclerosis
Lünemann, J. D., & Münz, C. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0038-y · Cited by 36
Metadata
- Authors
- Hjalgrim, H., Askling, J., Rostgaard, K., Hamilton-Dutoit, S., Frisch, M., Zhang, J.-S., Madsen, M., Rosdahl, N., Konradsen, H. B., Storm, H. H., & Melbye, M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-10-02
- Volume
- 349
- Issue
- 14
- Pages
- 1324-1332
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2086874336
- Cited by
- 433
- References
- 9
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.